New experimental drug shows breakthrough in Alzheimer's

Fox - Seattle
12 followers
2 Video Views·Jul 16, 2026
AI Generated·May contain errors
A glimmer of hope for the billions of Americans and families affected by Alzheimer's disease.
As Ted Linda reports, a new experimental drug is showing promise in the fight against Alzheimer's.
It may be a breakthrough in the fight against Alzheimer's disease.
Researchers say an experimental drug may help slow Alzheimer's in a different way than other
drugs have in the past.
This drug is a gene silencing therapy.
It works by targeting the mechanism that normally produces tau in the body.
Tau is protein in the brain and it's one part of a toxic duo which fuels Alzheimer's.
Medical researchers have tried to target tau in the past, but those attempts have failed
until now with a new experimental drug which lowered tau levels.
The lowest dose showed the greatest effect, but all doses showed some effect on five out of six
of those cognitive or functional scales that we used.
Biotechnology company Biogen did a study of about 400 people.
In addition to lowering tau, the study also showed slowed cognitive decline.
The positive results now prompting a larger study to prove the experimental drug's benefit.
This is really quite promising if it were to hold up in a larger appropriately
powered and designed trial.
And while some Alzheimer's drugs are given through the bloodstream by infusions or injections,
this one is injected in the fluid surrounding the spinal cord,
providing a straighter path to the brain.
Alzheimer's affects more than 7 million Americans and it's still not clear what exactly causes it.
With every trial, with everything that we do, you know, we learn so much more and so
I think this is really quite exciting and the team should be commended for the work.
I'm Ted Lindner, Fox News.
The USS Alexandria has arrived in Bremerton for decommissioning,
marking an end to 35 years in service.
According to the Kitsap Sun, the fast-attack submarine arrived at
Puget Sound Naval Shipyard Monday night.
The Alexandria was originally commissioned in 1991.
Over its decades in service, the submarine logged more than a million miles and completed 14
overseas deployments, supporting missions from the Arctic to the Indo-Pacific.
Bremerton Shipyard is the only facility in the world capable of dismantling the Navy's
nuclear-powered submarines.
